FDA clears group B strep test from Meridian

12/13/2011 | MedCityNews.com

The FDA has granted Meridian Bioscience clearance for its molecular diagnostic assay used to detect group B Streptococcus. The newly approved test, which the company says generates results in one hour using a simple process, marks the second from Meridian's illumigene product line to receive FDA clearance.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ